Neoechinulin a protects PC12 cells against MPP+-induced cytotoxicity

Journal of Antibiotics

Volumn 61, Issue 5, 2008, Pages 330-333

  Kajimura, Yoshihito ^a   Aoki, Toshiaki ^a   Kuramochi, Kouji ^a   Kobayashi, Susumu ^a   Sugawara, Fumio ^a   Watanabe, Nobuo ^a   Arai, Takao ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Alkaloid; Neurodegeneration; Parkinson's disease; Reactive oxygen nitrogen species

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALKALOID DERIVATIVE; NEOECHINULIN A; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; INDOLE ALKALOID; NEUROPROTECTIVE AGENT; PEROXYNITROUS ACID; PIPERAZINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; EUROTIUM RUBRUM; FUNGUS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; LETTER; METABOLISM;

EUROTIUM RUBRUM;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL SURVIVAL; ELECTRON TRANSPORT COMPLEX I; INDOLE ALKALOIDS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PEROXYNITROUS ACID; PIPERAZINES; RATS;

EID: 54049151992     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.48     Document Type: Article

References (13)

1. Maruyama K, Ohuchi T, Yoshida K, Shibata Y, Sugawara F, Arai T. Protective properties of neoechinulin A against SIN-1-induced neuronal cell death. J Biochem 136: 81-87 (2004)
2. Kimoto K, Aoki T, Shibata Y, Kamisuki S, Sugawara F, Kuramochi K, Nakazaki A, Kobayashi S, Kuroiwa K, Watanabe N, Arai T. Structure-activity relationships of neoechinulin A analogues with cytoprotection against peroxynitrite-induced PC12 cell death. J Antibiot 60: 614-621 (2007)
3. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822 (2003)
4. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39: 889-909 (2003)
5. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980 (1983)
6. Singer TP, Ramsay RR. Mechanism of the neurotoxicity of MPTR An update. FEBS Lett 274: 1-8 (1990)
7. Richardson JR, Caudle WM, Guillot TS, Watson JL, Nakamaru-Ogiso E, Seo BB, Sherer TB, Greenamyre JT, Yagi T, Matsuno-Yagi A, Miller GW. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Sci 95: 196-204 (2007)
8. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95: 7659-7663 (1998)
9. Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, orthotyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem 274: 34621-34628 (1999)
10. Cleeter MW, Cooper JM, Schapira AH. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 58: 786-789 (1992)
11. +)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem J 371: 151-164 (2003)
12. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484-509 (1996)
13. Matsuoka Y, Srere PA. Kinetic studies of citrate synthase from rat kidney and rat brain. J Biol Chem 248: 8022-8030 (1973)